Gilead Sciences, Inc. (GILD)
168.08
+0.13
(+0.08%)
USD |
NASDAQ |
Nov 13, 16:00
167.94
-0.14
(-0.08%)
After-Hours: 19:59
Gilead Sciences Net Income (TTM) : -3.863B for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.863B |
| June 30, 2026 | -3.24B |
| March 31, 2026 | 9.216B |
| December 31, 2025 | 8.51B |
| September 30, 2025 | 8.11B |
| June 30, 2025 | 6.311B |
| March 31, 2025 | 5.965B |
| December 31, 2024 | 480.00M |
| September 30, 2024 | 114.00M |
| June 30, 2024 | 1.033B |
| March 31, 2024 | 458.00M |
| December 31, 2023 | 5.613B |
| September 30, 2023 | 5.829B |
| June 30, 2023 | 5.443B |
| March 31, 2023 | 5.539B |
| December 31, 2022 | 4.566B |
| September 30, 2022 | 3.309B |
| June 30, 2022 | 4.109B |
| March 31, 2022 | 4.491B |
| December 31, 2021 | 6.201B |
| September 30, 2021 | 7.369B |
| June 30, 2021 | 5.136B |
| March 31, 2021 | 273.00M |
| December 31, 2020 | 89.00M |
| September 30, 2020 | 1.234B |
| Date | Value |
|---|---|
| June 30, 2020 | -287.00M |
| March 31, 2020 | 4.934B |
| December 31, 2019 | 5.364B |
| September 30, 2019 | 2.678B |
| June 30, 2019 | 5.945B |
| March 31, 2019 | 5.889B |
| December 31, 2018 | 5.46B |
| September 30, 2018 | 1.621B |
| June 30, 2018 | 2.234B |
| March 31, 2018 | 3.484B |
| December 31, 2017 | 4.644B |
| September 30, 2017 | 11.58B |
| June 30, 2017 | 12.19B |
| March 31, 2017 | 12.62B |
| December 31, 2016 | 13.49B |
| September 30, 2016 | 15.07B |
| June 30, 2016 | 16.34B |
| March 31, 2016 | 17.34B |
| December 31, 2015 | 18.11B |
| September 30, 2015 | 16.88B |
| June 30, 2015 | 15.02B |
| March 31, 2015 | 14.17B |
| December 31, 2014 | 12.06B |
| September 30, 2014 | 9.384B |
| June 30, 2014 | 7.445B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.817B |
| AbbVie, Inc. | 10.30B |
| Biogen, Inc. | 347.50M |
| Vertex Pharmaceuticals, Inc. | 3.976B |
| Amgen, Inc. | 9.391B |